Design, Synthesis, and Evaluation of Benzimidazole-Based HDAC Inhibitors: Synergistic Effect with FLT3 Inhibitor against AML via Modulation of Tumor Metabolism
Journal of Medicinal Chemistry · 09.07.2026 · 69 (13) · 15872-15887
DOI: 10.1021/acs.jmedchem.6c01013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 18.06.2026. Verfasst von Meng Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, Shandong Pediatric Drug Clinical Evaluation and R&D Research Center of Engineering Technology, The First Affiliated …. Hauptthemen laut MEDLINE: Benzimidazoles, fms-Like Tyrosine Kinase 3, Histone Deacetylase Inhibitors, Leukemia, Myeloid, Acute. Die Arbeit nennt 35 Literaturangaben. Gefördert von: Postdoctoral Innovation Project of Shandong Province, National Natural Science Foundation of China, Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacy, Shandong Pediatric Drug Clinical Evaluation and R&D Research Center of Engineering Technology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial…
- College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, Shandong 250355, China.
- Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250012, China.
- Phase I Clinical Trail Center, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong 250117, China.
Förderung
- Postdoctoral Innovation Project of Shandong Province
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
Zitieren
APA
Liu, M., Xue, J., Xue, C., Qi, H., Tan, Y., Wang, X., & Gao, S. (2026). Design, Synthesis, and Evaluation of Benzimidazole-Based HDAC Inhibitors: Synergistic Effect with FLT3 Inhibitor against AML via Modulation of Tumor Metabolism. Journal of Medicinal Chemistry, 69(13), 15872-15887. https://doi.org/10.1021/acs.jmedchem.6c01013
Vancouver
Liu M, Xue J, Xue C, Qi H, Tan Y, Wang X, et al. Design, Synthesis, and Evaluation of Benzimidazole-Based HDAC Inhibitors: Synergistic Effect with FLT3 Inhibitor against AML via Modulation of Tumor Metabolism. Journal of Medicinal Chemistry. 2026;69(13):15872-15887. doi:10.1021/acs.jmedchem.6c01013
BibTeX
@article{Liu2026,
author = {Liu, Meng and Xue, Junxin and Xue, Changning and Qi, Huibin and Tan, Yuanzhi and Wang, Xiaohan and Gao, Shan},
title = {Design, Synthesis, and Evaluation of Benzimidazole-Based HDAC Inhibitors: Synergistic Effect with FLT3 Inhibitor against AML via Modulation of Tumor Metabolism},
journal = {Journal of Medicinal Chemistry},
year = {2026},
volume = {69},
number = {13},
pages = {15872--15887},
doi = {10.1021/acs.jmedchem.6c01013}
}
EUVIMED